EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)

Sophie Rauschenberg, Elisabeth Orgler-Gasche, Didem Karakas Zeybek, Ivonne Regel, J-Matthias Löhr, Daniel Öhlund, Michael Günther, Lina Aguilera Munoz

International Journal of Oncology · 15.01.2026 · 68 (3)

DOI: 10.3892/ijo.2026.5848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 15.01.2026. Verfasst von Sophie Rauschenberg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department for Internal Medicine I, University Hospital Halle (Saale), D-06120 Halle (Saale), Germany. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the seventh leading cause of cancer‑related death worldwide in both men and women. While sex‑specific differences are increasingly recognized as critical determinants of health and disease, particularly in oncology, they remain markedly underexplored in PDAC. Emerging evidence suggests that sex differences influence numerous aspects of PDAC, including treatment response and prognosis. This knowledge gap represents a notable barrier to the development of effective, personalized therapeutic strategies for both sexes. The present review provides a comprehensive overview of the current knowledge on sex‑based differences in PDAC, encompassing epidemiology, risk factors, chemotherapy pharmacokinetics and toxicity, prognosis, therapeutic response, immune interactions, tumor microenvironment, tumor microbiota and molecular biomarkers. .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansFemalePrognosisMaleTumor MicroenvironmentSex FactorsRisk FactorsBiomarkers, TumorSex Characteristics

Stichwörter der Autor:innen

pancreatic cancerpancreatic ductal adenocarcinomaprecision oncologysex differencessex‑based medicine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department for Internal Medicine I, University Hospital Halle (Saale), D-06120 Halle (Saale), Germany.
  • Department of Medicine II, University Hospital LMU Munich, D-81377 Munich, Germany.
  • Graduate School of Health, Medical Biotechnology, Acibadem University, 34752 Istanbul, Turkey.
  • Department of Clinical Sciences, Karolinska Institute, 18288 Stockholm, Sweden.
  • Department of Diagnostics and Intervention (Oncology) and Wallenberg Centre of Molecular Medicine, Umeå University, 90187 Umeå, Sweden.
  • Institute of General Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Zitieren

APA

Rauschenberg, S., Orgler-Gasche, E., Karakas Zeybek, D., Regel, I., Löhr, J. M., Öhlund, D., Günther, M., & Aguilera Munoz, L. (2026). Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review). International Journal of Oncology, 68(3). https://doi.org/10.3892/ijo.2026.5848

Vancouver

Rauschenberg S, Orgler-Gasche E, Karakas Zeybek D, Regel I, Löhr JM, Öhlund D, et al. Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review). International Journal of Oncology. 2026;68(3). doi:10.3892/ijo.2026.5848

BibTeX
@article{Rauschenberg2026,
  author = {Rauschenberg, Sophie and Orgler-Gasche, Elisabeth and Karakas Zeybek, Didem and Regel, Ivonne and Löhr, J-Matthias and Öhlund, Daniel and Günther, Michael and Aguilera Munoz, Lina},
  title = {Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)},
  journal = {International Journal of Oncology},
  year = {2026},
  volume = {68},
  number = {3},
  doi = {10.3892/ijo.2026.5848}
}
Kostenlos starten →